星形胶质细胞CXCL12/CXCR7信号通路在脑缺血损伤中的作用及机制研究
批准号:
81971873
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
曲彦
依托单位:
学科分类:
器官功能衰竭与支持
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
曲彦
中文摘要
趋化因子CXCL12在缺血性脑损伤的组织修复及功能重建中发挥重要作用。近期研究表明CXCL12受体CXCR7在缺血性中风后皮质梗塞周围区域的表达显著增加,且主要定位在星形胶质细胞;而在梗塞核心的表达却明显降低,提示星形胶质细胞CXCL12-CXCR7信号通路在缺血性脑损伤中可能发挥着重要作用。但是星形胶质细胞CXCL12-CXCR7介导的信号通路在脑缺血中的作用及可能的分子机制尚不清楚。本项目拟构建星形胶质细胞靶向高表达及干涉CXCR7病毒,在缺氧细胞模型,局灶脑缺血再灌注大鼠及CXCR7基因敲除小鼠上,阐明星形胶质细胞CXCR7是CXCL12介导的信号分子通路的关键受体,并可能通过CXCL12-CXCR7信号通路参与脑缺血星形胶质细胞的功能调控;并进一步探讨星形胶质细胞CXCL12/CXCR7通路通过何种机制保护脑缺血神经元的功能。研究结果将为防治缺血性脑中风提供新的靶点和治疗策略。
英文摘要
Stromal cell-derived factor 1 (SDF-1), also known as C-X-C motif chemokine 12 (CXCL12), is a chemokine protein that ubiquitously expressed in many tissues and all cell types in the central nervous system. It has been reported that CXCL12 plays an important role in brain repair after ischemic stroke. Recent study has shown that ischemic stroke in human leads to an increase in the expression of CXCL12 and its receptor CXCR7, but not CXCR4, in the peri-infarct cerebral cortex. In addition, CXCR7 protein was predominantly expressed in astrocytes in the penumbra of ischemic brain in human, suggesting that CXCR7-mediated signaling pathway in astrocytes might play a key role in ischemic brain injury. However, the role of CXCR7 in astrocytes and its possible molecular mechanisms underlying its protective effects on neurons in cortex and CA1 after ischemia are not elucidated. Therefore, in this study, we will discuss the effects of astrocytic CXCL12-CXCR7-mediated signaling on brain injury in hypoxic cell model, focal cerebral ischemia reperfusion rats and astrocyte-targeting CXCR7 knockout mice. We will elucidate that CXCR7 might be the primary receptor of CXCL12 in astrocytes and CXCR7-mediated signaling might be involved in the functional regulation of astrocytes in ischemic stroke brain. In addition, we will further explore the underlying mechanisms for the regulation of CXCL12/CXCR7 signaling in astrocytes and its effect on the function of ischemic neurons after ischemia. This will provide new targets and therapeutic strategies for the prevention and treatment of ischemic stroke.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
10.3760/cma.j.cn121430-20211221-01898
发表时间:
2022
期刊:
中华危重病急救医学
影响因子:
作者:
[王雪颖, 孟海宁, 王松梅, 谢伟峰, 曲彦]
通讯作者:
曲彦
DOI:
10.3760/cma.j.cn121430-20230110-00011
发表时间:
2023
期刊:
中华危重病急救医学
影响因子:
作者:
[梁永慧, 关纯, 孟海宁, 谢伟峰, 孟祥祺, 曲彦]
通讯作者:
曲彦
DOI:
10.3760/cma.j.cn121430-20230103-00003
发表时间:
2023
期刊:
中华危重病急救医学
影响因子:
作者:
[蒋子鸣, 王洪亮, 王素梅, 关纯, 曲彦]
通讯作者:
曲彦
DOI:
10.3389/fnmol.2022.1026927
发表时间:
2022
期刊:
FRONTIERS IN MOLECULAR NEUROSCIENCE
影响因子:
4.8
作者:
[Meng, Haining, Li, Shaohua, Li, Qingshu, Wang, Yuqin, Wang, Guoan, Qu, Yan]
通讯作者:
Qu, Yan
BAG-1/HSP70相互作用在脑缺血神经元凋亡中的保护作用及分子机制研究
-
批准号:81571938
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2015
-
负责人:曲彦
-
依托单位:
国内基金
海外基金